Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Andrew Dalovisio"'
Autor:
Joshua F. Zeidner, Tara L. Lin, Carlos E. Vigil, Gil Fine, M. Yair Levy, Aziz Nazha, Jordi Esteve, Daniel J. Lee, Karen Yee, Andrew Dalovisio, Eunice S. Wang, Juan M. Bergua Burgues, Jeffrey Schriber, Mark R. Litzow, Olga Frankfurt, Teresa Bernal Del Castillo, Vijaya Raj Bhatt, Bhavana Bhatnagar, Priyanka Mehta, Richard Dillon, Maria Vidriales Vicente, Stephen Anthony, David Bearss, Pau Montesinos, B. Douglas Smith
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/7122a437fe1c4abaa373b01b87a4c63e
Autor:
Mark R. Litzow, Stephen A. Strickland, Kelly Haines, Gaetano Bonifacio, Andrew Dalovisio, Alysha Barbera, Gail J. Roboz, Alexander E. Perl, Kendra Sweet, Das Purkayastha
Publikováno v:
Leukemia & Lymphoma. 61:3146-3153
Approval of midostaurin, a multikinase inhibitor, in combination with chemotherapy for the treatment of adults with newly diagnosed FLT3 mutation–positive acute myeloid leukemia, was based on the p...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::431d01d0bdca57dd636a57e3e50dd8c8
https://doi.org/10.1080/10428194.2020.1805109
https://doi.org/10.1080/10428194.2020.1805109
Autor:
Claudia Haferlach, Patricia T. Greipp, Nicole L. Hoppman, Linda B. Baughn, Li Huang, Beth A. Pitel, Jennifer L. Oliveira, Dong Chen, Patrick R. Blackburn, Sarah H. Johnson, Rhett P. Ketterling, Jess F. Peterson, George Vasmatzis, Andrew Dalovisio, James B. Smadbeck, Adam J. Wood
Publikováno v:
Cancer Genetics. 241:67-71
Secondary acquisition of t(9;22)(q34;q11.2)/BCR-ABL1 fusion in the context of de novo acute myeloid leukemia (AML) with inv(3)(q21q26)/GATA2-MECOM rearrangement has been rarely reported. Furthermore, t(2;11)(p23;q23)/KMT2A-ASXL2 fusion has been rarel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fc077ae69db5ffedb47ae71426e6883
https://doi.org/10.1016/j.cancergen.2019.12.005
https://doi.org/10.1016/j.cancergen.2019.12.005
Autor:
Carlos E. Vigil, Eunice S. Wang, María Belén Vidriales Vicente, Priyanka Mehta, David J. Bearss, Stephen P. Anthony, Joshua F. Zeidner, Andrew Dalovisio, Olga Frankfurt, M. Yair Levy, Richard Dillon, Mark R. Litzow, Tara L. Lin, Aziz Nazha, Pau Montesinos, Daniel J. Lee, Jeffrey Schriber, Teresa Bernal Del Castillo, Karen W.L. Yee, Jordi Esteve, Juan Miguel Bergua Burgues, Gil Fine, B. Douglas Smith, Bhavana Bhatnagar, Vijaya Raj Bhatt
Publikováno v:
Blood Cancer Journal
BLOOD CANCER JOURNAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)
BLOOD CANCER JOURNAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3942dd1e54bd08a10bcfddea324cde57
http://europepmc.org/articles/PMC8557202
http://europepmc.org/articles/PMC8557202
Autor:
Daniel J. Lee, Andrew Dalovisio, Vijaya Raj Bhatt, B. Douglas Smith, Joshua F. Zeidner, Gil Fine, Eunice S. Wang, David J. Bearss, Kathryn S. Kolibaba, Pau Montesinos, Stephen P. Anthony
Publikováno v:
Blood. 136:48-50
Background: Alvocidib is an investigational cyclin-dependent kinase-9 (CDK9) inhibitor that can suppress RNA polymerase II-mediated transcription of genes implicated in leukemia cell survival, including myeloid leukemia cell-1 (MCL-1). MCL-1 is an an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e76ea8b5ed3a08cd03334caae7f4da58
https://doi.org/10.1182/blood-2020-133796
https://doi.org/10.1182/blood-2020-133796
Autor:
Michael P. Chu, Michael Damore, Noopur Raje, Hoi Kei Lon, Cynthia Basu, Nizar J. Bahlis, Cristina Gasparetto, Michael Sebag, Caitlin Costello, Bhagirathbhai Dholaria, Suzanne Trudel, Harman Dube, Melhem Solh, Andrew Dalovisio, Athanasia Skoura, Moshe Yair Levy, Andrzej Jakubowiak, Michael H. Tomasson, Alexander M. Lesokhin, Edward Chan
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S195-S196 (2021)
Objectives Elranatamab (PF-06863135) is a humanized bispecific monoclonal antibody (IgG2a) that targets BCMA, a member of the tumor necrosis factor receptor superfamily expressed in multiple myeloma, and CD3 on T cells. We reported results for intrav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::579f0fee7dd908721e3ee7f35b33920c
https://doi.org/10.1016/j.htct.2021.10.331
https://doi.org/10.1016/j.htct.2021.10.331
Autor:
Gail J, Roboz, Stephen A, Strickland, Mark R, Litzow, Andrew, Dalovisio, Alexander E, Perl, Gaetano, Bonifacio, Kelly, Haines, Alysha, Barbera, Das, Purkayastha, Kendra, Sweet
Publikováno v:
Leukemialymphoma. 61(13)
Approval of midostaurin, a multikinase inhibitor, in combination with chemotherapy for the treatment of adults with newly diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::715c098d764da48acaedd84dca0daf42
https://pubmed.ncbi.nlm.nih.gov/32812818
https://pubmed.ncbi.nlm.nih.gov/32812818
Autor:
Moshe Levy, Nizar Bahlis, Noopur Raje, Caitlin Costello, Bhagirathbhai Dholaria, Melhem Solh, Michael Tomasson, Harman Dube, Michael Damore, Hoi Kei Lon, Cynthia Basu, Athanasia Skoura, Edward Chan, Suzanne Trudel, Andrzej Jakubowiak, Michael Chu, Cristina Gasparetto, Andrew Dalovisio, Michael Sebag, Alexander Lesokhin
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9787ce36a56d2914febc77e078531dad
https://doi.org/10.1016/s2152-2650(21)01578-0
https://doi.org/10.1016/s2152-2650(21)01578-0
Autor:
Nizar J. Bahlis, Feng Liu, Caitlin Costello, Melhem Solh, Moshe Yair Levy, Athanasia Skoura, Andrzej Jakubowiak, Alexander M. Lesokhin, Andrew Dalovisio, Harman Dube, Noopur Raje, Suzanne Trudel, Michael H. Tomasson, Edward Chan, Bhagirathbhai Dholaria, Cristina Gasparetto, Michael Sebag, Michael P Chu, Cynthia Basu, Kai Hsin Liao
Publikováno v:
Journal of Clinical Oncology. 39:8006-8006
8006 Background: Elranatamab (PF-06863135) is a humanized bispecific monoclonal antibody (IgG2a) that targets BCMA, a member of the tumor necrosis factor receptor superfamily expressed in MM, and CD3 on T cells. We reported results for intravenous (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::929f753692e7d9a92e639ccc7318e7d5
https://doi.org/10.1200/jco.2021.39.15_suppl.8006
https://doi.org/10.1200/jco.2021.39.15_suppl.8006
Autor:
Kelly Haines, Kendra Sweet, Gaetano Bonifacio, Stephen A. Strickland, Mark R. Litzow, Alexander E. Perl, Gail J. Roboz, Das Purkayastha, Alysha Barbera, Andrew Dalovisio
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S202-S203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fa986b556105a0db9973c57c2ddaccf
https://doi.org/10.1016/j.clml.2018.07.053
https://doi.org/10.1016/j.clml.2018.07.053